Latest filing published 02 Oct 2026 for Xeris Biopharma Holdings, Inc., €138k. Read the official filing
Filings by Beth Hecht span 3 companies, the busiest being Xeris Biopharma Holdings, Inc., Iterum Therapeutics plc and Xeris Pharmaceuticals Inc. Between 5 October 2021 and 1 October 2026, the trades on record add up to 22 filings.
The open-market record consists of 10 sales worth €1.2M, with no purchase. Besides market trades, the filings include 8 share grants and 3 option exercises. 2026 to date brings no purchases and 7 sales.
The latest filing, published on 2 October 2026, reports an open-market sale of €138k in Xeris Biopharma Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations